Product Description

Skin malignancies are the most prevalent cancers, and plastic surgeons are often the primary physicians engaged in diagnosis and management of these lesions. Proper management includes distinguishing between high-risk and low-risk lesions and determining treatment accordingly. The aim of this Continuing Medical Education article is to review the diagnosis and management of common and uncommon facial skin malignancies, including basal cell carcinoma, squamous cell carcinoma, actinic keratosis, keratoacanthoma, Merkel cell carcinoma, atypical fibroxanthoma, sebaceous carcinoma, and microcystic adnexal carcinoma.

Learning Objectives

After viewing this course, the participant should be able to:

1. Identify clinical features of nonmelanoma skin cancer.

2. Distinguish low-risk versus high-risk basal cell carcinoma and squamous cell carcinoma.

3. Define appropriate management based on current guidelines for various types of basal cell and squamous cell carcinoma.

4. Determine a safe and effective surgical plan.

Faculty

Karen L Connolly, MD; Kishwer S Nehal, MD; Joseph J. Disa, MD

Plastic and Reconstruction Surgery® Editors:

Editor-in-Chief: Rod J. Rohrich, MD

Co-Editor: James M. Stuzin, MD

Section Editor: Donald H. Lalonde, MD

Accreditation Information

Patient Safety Credit: 0.5

Media: Journal Article, Video

Publish Date: 1/1/2017

Estimated time to complete this course: 1.0 hour

Directly provided by the American Society of Plastic Surgeons^® (ASPS^®)

Accreditation Statement

The American Society of Plastic Surgeons (ASPS) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

The ASPS designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Intended Audience

This educational activity is intended for plastic surgery practitioners, residents, and other healthcare professionals interested in translating expanded knowledge into practice for the improvement of patient outcomes in plastic and reconstructive surgery.

Disclosures

Dr. Rohrich, MD is the Principal/Co-Principal Investigator of research grants awarded to the University of Texas Southwestern Medical Center, Dallas, from Medicis, Mentor, and Contura Pharmaceutical. All research funds are provided directly to UT Southwestern. Dr. Stuzin has no relevant financial relationships or affiliations to disclose. Dr. Lalonde is a consultant for ASSI Instruments. None of the authors have any relevant financial relationships or affiliations to disclose.

All ASPS staff members managing this activity have no relevant financial relationships or affiliations to disclose. All identified conflicts of interest have been resolved and the educational content thoroughly vetted by ASPS for fair balance, scientific objectivity, and appropriateness of patient care recommendations. The ASPS also requires faculty/authors to disclose when off-label/unapproved uses of a product are discussed in a CME activity or included in related materials.

Product Code: 20878